Lütgehetmann M - Search Results

1

Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice.

Giersch K, Homs M, Volz T, Helbig M, Allweiss L, Lohse AW, Petersen J, Buti M, Pollicino T, Sureau C, Dandri M, Lütgehetmann M. Giersch K, et al. Among authors: lutgehetmann m. Sci Rep. 2017 Jun 16;7(1):3757. doi: 10.1038/s41598-017-03946-9. Sci Rep. 2017. PMID: 28623307 Free PMC article.

2

Animal models for the study of HBV replication and its variants.

Dandri M, Volz TK, Lütgehetmann M, Petersen J. Dandri M, et al. Among authors: lutgehetmann m. J Clin Virol. 2005 Dec;34 Suppl 1:S54-62. doi: 10.1016/s1386-6532(05)80011-3. J Clin Virol. 2005. PMID: 16461225 Review.

3

Small animal model systems for studying hepatitis B virus replication and pathogenesis.

Dandri M, Lutgehetmann M, Volz T, Petersen J. Dandri M, et al. Among authors: lutgehetmann m. Semin Liver Dis. 2006 May;26(2):181-91. doi: 10.1055/s-2006-939760. Semin Liver Dis. 2006. PMID: 16673296 Review.

4

Morphological and functional analysis of rat hepatocyte spheroids generated on poly(L-lactic acid) polymer in a pulsatile flow bioreactor.

Török E, Vogel C, Lütgehetmann M, Ma PX, Dandri M, Petersen J, Burda MR, Siebert K, Düllmann J, Rogiers X, Pollok JM. Török E, et al. Among authors: lutgehetmann m. Tissue Eng. 2006 Jul;12(7):1881-90. doi: 10.1089/ten.2006.12.1881. Tissue Eng. 2006. PMID: 16889518 Free article.

5

Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B.

Wursthorn K, Lutgehetmann M, Dandri M, Volz T, Buggisch P, Zollner B, Longerich T, Schirmacher P, Metzler F, Zankel M, Fischer C, Currie G, Brosgart C, Petersen J. Wursthorn K, et al. Among authors: lutgehetmann m. Hepatology. 2006 Sep;44(3):675-84. doi: 10.1002/hep.21282. Hepatology. 2006. PMID: 16941693

6

Temporary HBV resolution in an HIV-coinfected patient during HBV-directed combination therapy followed by relapse of HBV.

Wursthorn K, Buggisch P, Lutgehetmann M, Zollner B, Petersen J. Wursthorn K, et al. Among authors: lutgehetmann m. Antivir Ther. 2006;11(5):647-52. Antivir Ther. 2006. PMID: 16964835

7

Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients.

Volz T, Lutgehetmann M, Wachtler P, Jacob A, Quaas A, Murray JM, Dandri M, Petersen J. Volz T, et al. Among authors: lutgehetmann m. Gastroenterology. 2007 Sep;133(3):843-52. doi: 10.1053/j.gastro.2007.06.057. Epub 2007 Jul 3. Gastroenterology. 2007. PMID: 17854594

8

Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.

Petersen J, Dandri M, Mier W, Lütgehetmann M, Volz T, von Weizsäcker F, Haberkorn U, Fischer L, Pollok JM, Erbes B, Seitz S, Urban S. Petersen J, et al. Among authors: lutgehetmann m. Nat Biotechnol. 2008 Mar;26(3):335-41. doi: 10.1038/nbt1389. Epub 2008 Feb 24. Nat Biotechnol. 2008. PMID: 18297057

9

Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication.

Lutgehetmann M, Volzt T, Quaas A, Zankel M, Fischer C, Dandri M, Petersen J. Lutgehetmann M, et al. Antivir Ther. 2008;13(1):57-66. Antivir Ther. 2008. PMID: 18389899 Clinical Trial.

10

Virion half-life in chronic hepatitis B infection is strongly correlated with levels of viremia.

Dandri M, Murray JM, Lutgehetmann M, Volz T, Lohse AW, Petersen J. Dandri M, et al. Among authors: lutgehetmann m. Hepatology. 2008 Oct;48(4):1079-86. doi: 10.1002/hep.22469. Hepatology. 2008. PMID: 18697217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters